Short answer: The labels say no. Wegovy's label says using it with other semaglutide products or any other GLP-1 receptor agonist is not recommended, and Zepbound and Saxenda carry the same line for their own drugs. That covers pairs that share an ingredient under different brand names, such as Ozempic with Wegovy or Mounjaro with Zepbound, and the insulin combination pens Xultophy and Soliqua.
The line sits in the Limitations of Use, near the top of each label:
| Label | Not recommended with |
|---|---|
| Wegovy (semaglutide) injection and tablets | Other semaglutide products or any other GLP-1 receptor agonist |
| Zepbound (tirzepatide) | Other tirzepatide products or any GLP-1 receptor agonist |
| Saxenda (liraglutide) | Other liraglutide products or any other GLP-1 receptor agonist |
| Xultophy 100/3.6 (insulin degludec and liraglutide) | Any other liraglutide product or another GLP-1 receptor agonist |
| Soliqua 100/33 (insulin glargine and lixisenatide) | Any other product containing a GLP-1 receptor agonist |
Zepbound's label describes tirzepatide as acting on two hormone receptors, GIP and GLP-1, and still lists GLP-1 medicines as ones not to combine with it. The Wegovy line applies to its tablets as well as its injection, so a pill form does not change the answer.
Some pairs are the same medicine sold for different uses. Ozempic and Wegovy both contain semaglutide; Mounjaro and Zepbound both contain tirzepatide. Taking one of each means two doses of the same drug. The insulin combination pens repeat the pattern: Xultophy contains liraglutide, the same drug as Saxenda, and Soliqua contains lixisenatide, another GLP-1 medicine. The Ozempic vs Wegovy and Mounjaro vs Zepbound pages compare the pairs.
The Soliqua label shows what doubling can mean. It says more than 60 units a day of Soliqua can overdose its lixisenatide part, and that it should not be used with other GLP-1 medicines.
Moving from one GLP-1 medicine to another happens, for example when supply or coverage changes. That is a stop and a start rather than two at once, and the timing and starting dose are set by the prescriber, who knows the dose you were on and how you tolerated it. Each label has its own dose steps; see the Wegovy and Zepbound dosing pages.
If a missed week comes up during a switch, the missed-dose rules are on pages like missed Ozempic dose.
During a switch it is easy to end up with two different pens in the fridge at the same time. Dose Track keeps each medicine as its own entry and logs every dose against it, so an overlap is easy to spot and the prescriber can see when one ended and the other began.
Read more on Dose Track: Ozempic vs Wegovy · Mounjaro vs Zepbound · GLP-1 receptor agonist · Saxenda side effects